Global Vanishing Bone Disease Market Size, Share, Forecast Report, 2020-2027

The global vanishing bone disease market size is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global vanishing bone disease industry is expected to register a CAGR ~6.1 % during the forecast period of 2018–2023.

Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteopenia and fracture. Furthermore, the exact cause of the disease is unknown. However, it is considered to be caused due to the improper development of the lymphatic system.

According to the National Center for Advancing Translational Sciences (NIH), in 2016, the number of cases of vanishing bone disease reported ranged from 64 to 200 cases globally. The growing occurrence of the disease is the key driver for the growth of the market. Furthermore, current research for the development of the effective therapeutic intervention for the disease treatment is expected to contribute to the growth of the market.
Segmentation

The global vanishing bone disease market is segmented on the basis of the diagnosis, treatment, and end-user.

On the basis of diagnosis, the market is classified as X-rays, CT scans, MRIs, ultrasound, nuclear medicine, and others.

The global vanishing bone disease market on the basis of treatment is segmented as medical therapy and radiation therapy. The medicine therapy is segmented into bisphosphonates, vitamin D, interferon, a-2b interferon, calcium, adrenal extracts, androgen, bleomycin, and others. The radiation therapy is further segmented into chest drainage, thoracic duct ligation, pleurodesis, pleurectomy, and others.

On the basis of end-user, the global vanishing bone disease market is segmented as hospitals & clinics, diagnostic centers, ambulatory surgical centers, and others.
Key Players

Varian Medical Systems, Inc., Elekta AB, C. R. Bard, Inc., Teleflex Incorporated, Vygon S.A. Medtronic plc., Cook Medical, Smiths Medical, ATMOS MedizinTechnik GmbH & Co. KG, Merck & Co., Sanofi-Aventis, F. Hoffmann-La Roche AG, and Novartis International AG are some prominent players in this market.

Global Vanishing Bone Disease Market, by Diagnosis

• X-rays
• CT Scans
• MRIs
• Ultrasound
• Nuclear Medicine
• Others

Global Vanishing Bone Disease Market, by Treatment

• Medicine Therapy
• Bisphosphonates
• Vitamin D
• Interferon
• a-2b Interferon
• Calcium
• Adrenal extracts
• Androgens
• Bleomycin
• Others
• Radiation Therapy
• Chest drainage
• Thoracic Duct Ligation
• Pleurodesis
• Pleurectomy
• Others

Global Vanishing Bone Disease Market, by End-User

• Hospitals and clinics
• Diagnostic centers
• Ambulatory surgical centers